Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 15/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4962172 | 0.97 | TACR3 (0.50) | TACR3LMNAL3MBTL1 | |
| SCHEMBL4961957 | 0.95 | TACR3 (0.51) | TACR3LMNAL3MBTL1 | |
| SCHEMBL4963091 | 0.91 | LMNA (0.60) | TACR3LMNAL3MBTL1 | |
| SCHEMBL4963863 | 0.83 | LMNA (0.54) | TACR3LMNAL3MBTL1 | |
| SCHEMBL4962076 | 0.81 | LMNA (0.57) | TACR3LMNAL3MBTL1 | |
| SCHEMBL4961927 | 0.81 | LMNA (0.52) | TACR3LMNAL3MBTL1NPC1RAB9A | |
| SCHEMBL4963768 | 0.80 | LMNA (0.52) | TACR3LMNAL3MBTL1NPC1RAB9A | |
| SCHEMBL4967704 | 0.79 | TACR3 (0.74) | TACR3 | |
| SCHEMBL4966074 | 0.79 | TACR3 (0.74) | TACR3 | |
| SCHEMBL4965436 | 0.78 | TACR3 (0.70) | TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896418-A1 | QUINOLINE 3 -SULFONATE ESTERS AS NK3 RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2008-03-12 | — | — | EP | claimed |
| WO-2006137789-A1 | Quinoline 3 -sulfonate esters as NK3 receptor modulators | ASTRAZENECA AB (SE) | 2006-12-28 | — | — | WO | claimed |
| EP-1896418-A1 | QUINOLINE 3 -SULFONATE ESTERS AS NK3 RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2008-03-12 | — | — | EP | disclosed |
| WO-2006137789-A1 | Quinoline 3 -sulfonate esters as NK3 receptor modulators | ASTRAZENECA AB (SE) | 2006-12-28 | — | — | WO | disclosed |